ALFA Filings
Every announcement, straight from the exchange
Every Speciality Medicines other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Limited has appointed Capital Bridge Advisory Service Private Limited as its Investor and Public Relations agency to enhance its investor relations and communication efforts.
Speciality Medicines Ltd submitted contact details of Key Managerial Personnel authorised under SEBI Regulation 30(5). The authorised KMPs include the Chairman & Managing Director, Whole-time Director, and Company Secretary. This administrative update ensures compliance with materiality disclosure requirements.